How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology

Wen-Qiang Che; Yuan-Jie Li; Chi-Kwan Tsang; Yu-Jiao Wang; Zheng Chen; Xiang-Yu Wang; An-Ding Xu; Jun Lyu

doi:10.1186/s40779-023-00488-2

Your Location：

Home >

Browse articles >

How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology

REVIEW | Updated：2025-12-13

- How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology
- How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology
- MMR 2024年11卷第5期页码：686-696
- Affiliations：
  
  1.Department of Neurosurgery, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  2.Department of Clinical Research, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  3.Planning & Discipline Construction Office, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  4.Clinical Neuroscience Institute, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  5.Department of Pathology, Shanxi Provincial People’s Hospital, Taiyuan 030012, China
  6.Department of Urology, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  7.Department of Neurology, the First Affiliated Hospital of Jinan University, Guangzhou 510632, China
  8.Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Guangzhou 510632, China
- Author bio：
  
  *wang_xy123@126.com;
  tlil@jnu.edu.cn;
  lyujun2020@jnu.edu.cn
- Funds：
  
  The study was supported by the Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization(2021B1212040007);the Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University, China(JNU1AF-CFTP-2022-a01235);the Science and Technology Projects in Guangzhou, China(202201020054;2023A03J1032)
- DOI：10.1186/s40779-023-00488-2
  中图分类号：
- 纸质出版：2024-10
- Accepted：
Scan QR Code
How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology[J]. MMR, 2024,11(5):686-696.

Cite this article as: Che WQ, Li YJ, Tsang CK, Wang YJ, Chen Z, Wang XY, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. Mil Med Res. 2023;10(1):50.
How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology[J]. MMR, 2024,11(5):686-696. DOI： 10.1186/s40779-023-00488-2.

Cite this article as: Che WQ, Li YJ, Tsang CK, Wang YJ, Chen Z, Wang XY, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. Mil Med Res. 2023;10(1):50. DOI： 10.1186/s40779-023-00488-2.

摘要

Abstract

In the United States (US)

the Surveillance

Epidemiology

and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. This program aims to provide a database about cancer incidence and survival for studies of surveillance and the development of analytical and methodological tools in the cancer field. Currently

the SEER program covers approximately half of the total cancer patients in the US. A growing number of clinical studies have applied the SEER database in various aspects. However

the intrinsic features of the SEER database

such as the huge data volume and complexity of data types

have hindered its application. In this review

we provided a systematic overview of the commonly used methodologies and study designs for retrospective epidemiological research in order to illustrate the application of the SEER database. Therefore

the goal of this review is to assist researchers in the selection of appropriate methods and study designs for enhancing the robustness and reliability of clinical studies by mining the SEER database.

关键词

Keywords

references

Park HS , Lloyd S , Decker RH , Wilson LD , Yu JB . Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance . Curr Probl Cancer . 2012 ; 36 ( 4 ): 183 – 90 .

Malmgren JA , Calip GS , Atwood MK , Mayer M , Kaplan HG . Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011 . Cancer . 2020 ; 126 ( 2 ): 390 – 9 .

Sasaki K , Jabbour E , Short NJ , Jain N , Ravandi F , Pui CH , et al . Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980–2017 . Am J Hematol . 2021 ; 96 ( 6 ): 650 – 8 .

Miller KD , Nogueira L , Devasia T , Mariotto AB , Yabroff KR , Jemal A , et al . Cancer treatment and survivorship statistics, 2022 . CA Cancer J Clin . 2022 ; 72 ( 5 ): 409 – 36 .

Mehta RS , Lenzner D , Argiris A . Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study . Ann Surg Oncol . 2012 ; 19 ( 3 ): 722 – 7 .

Zavala VA , Bracci PM , Carethers JM , Carvajal-Carmona L , Coggins NB , Cruz-Correa MR , et al . Cancer health disparities in racial/ethnic minorities in the United States . Br J Cancer . 2021 ; 124 ( 2 ): 315 – 32 .

Daly MC , Paquette IM . Surveillance, Epidemiology, and End Results (SEER) and SEER-medicare databases: use in clinical research for improving colorectal cancer outcomes . Clin Colon Rectal Surg . 2019 ; 32 ( 1 ): 61 – 8 .

Brar G , Greten TF , Graubard BI , Mcneel TS , Petrick JL , Mcglynn KA , et al . Hepatocellular carcinoma survival by etiology: a SEER-Medicare database analysis . Hepatol Commun . 2020 ; 4 ( 10 ): 1541 – 51 .

Barzi A , Zhou K , Wang S , Dodge JL , El-Khoueiry A , Setiawan VW . Etiology and outcomes of hepatocellular carcinoma in an ethnically diverse population: the multiethnic cohort . Cancers (Basel) . 2021 ; 13 ( 14 ): 3476 .

Tonidandel S , King EB , Cortina JM . Big data methods: leveraging modern data analytic techniques to build organizational science . Organ Res Methods . 2018 ; 21 ( 3 ): 525 – 47 .

Hasan MM , Popp J , Oláh J . Current landscape and influence of big data on finance . J Big Data . 2020 ; 7 ( 1 ): 1 – 17 .

Zhang L , Wang H , Li Q , Zhao MH , Zhan QM . Big data and medical research in China . BMJ . 2018 ; 360 : j5910 .

Alharthi A , Krotov V , Bowman M . Addressing barriers to big data . Bus Horizons . 2017 ; 60 ( 3 ): 285 – 92 .

Yang J , Li Y , Liu Q , Li L , Feng A , Wang T , et al . Brief introduction of medical database and data mining technology in big data era . J Evid Based Med . 2020 ; 13 ( 1 ): 57 – 69 .

Wu WT , Li YJ , Feng AZ , Li L , Huang T , Xu AD , et al . Data mining in clinical big data: the frequently used databases, steps, and methodological models . Mil Med Res . 2021 ; 8 ( 1 ): 44 .

Boateng EY , Abaye DA . A review of the logistic regression model with emphasis on medical research . JDAIP . 2019 ; 7 ( 4 ): 190 – 207 .

Sur P , Candès EJ . A modern maximum-likelihood theory for high-dimensional logistic regression . Proc Natl Acad Sci U S A . 2019 ; 116 ( 29 ): 14516 – 25 .

Norton EC , Dowd BE , Maciejewski ML . Odds ratios-current best practice and use . JAMA . 2018 ; 320 ( 1 ): 84 – 5 .

Shipe ME , Deppen SA , Farjah F , Grogan EL . Developing prediction models for clinical use using logistic regression: an overview . J Thorac Dis . 2019 ; 11 ( Suppl 4 ): S574 – 84 .

Che W , Wang Y , Wang X , Lyu J . Association between age and the presence and mortality of breast cancer synchronous brain metastases in the United States: a neglected SEER analysis . Front Public Health . 2022 ; 10 : 1000415 .

Lorimer PD , Motz BM , Watson M , Trufan SJ , Prabhu RS , Hill JS , et al . Enteral feeding access has an impact on outcomes for patients with esophageal cancer undergoing esophagectomy: an analysis of SEERMedicare . Ann Surg Oncol . 2019 ; 26 : 1311 – 9 .

Jr Bartek J , Dhawan S , Thurin E , Alattar A , Gulati S , Rydenhag B , et al . Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database . J Neurooncol . 2020 ; 148 ( 2 ): 281 – 90 .

Chang W , Wei Y , Ren L , Jian M , Chen Y , Chen J , et al . Short-term and long-term outcomes of robotic rectal surgery-from the real word data of 1145 consecutive cases in China . Surg Endosc . 2020 ; 34 ( 9 ): 4079 – 88 .

Hankinson TC , Dudley RWR , Torok MR , Patibandla MR , Dorris K , Poonia S , et al . Short-term mortality following surgical procedures for the diagnosis of pediatric brain tumors: outcome analysis in 5533 children from SEER, 2004–2011 . J Neurosurg Pediatr . 2016 ; 17 ( 3 ): 289 – 97 .

Wu C , Zhao Y , Zhang Y , Yang Y , Su W , Yang Y , et al . Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients . J Adv Res . 2022 ; 37 : 197 – 208 .

Hyder O , Dodson RM , Sachs T , Weiss M , Mayo SC , Choti MA , et al . Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis . Surgery . 2014 ; 155 ( 1 ): 85 – 93 .

Che W , Wang Y , Wang X , Lyu J . Midlife brain metastases in the United States: Is male at risk? . Cancer Med . 2022 ; 11 ( 4 ): 1202 – 16 .

Coffman DL , Zhou J , Cai X . Comparison of methods for handling covariate missingness in propensity score estimation with a binary exposure . BMC Med Res Methodol . 2020 ; 20 ( 1 ): 168 .

Cox DR . Regression models and life-tables . J R Stat Soc B . 1972 ; 34 ( 2 ): 187 – 202 .

Moolgavkar SH , Chang ET , Watson HN , Lau EC . An assessment of the Cox proportional hazards regression model for epidemiologic studies . Risk Anal . 2018 ; 38 ( 4 ): 777 – 94 .

He QL , Gao SW , Qin Y , Huang RC , Chen CY , Zhou F , et al . Gastrointestinal dysfunction is associated with mortality in severe burn patients: a 10-year retrospective observational study from South China . Mil Med Res . 2022 ; 9 ( 1 ): 49 .

Kalbfleisch JD , Schaubel DE . Fifty years of the cox model . Annu Rev Stat Appl . 2023 ; 10 : 1 – 23 .

Martin AM , Cagney DN , Catalano PJ , Warren LE , Bellon JR , Punglia RS , et al . Brain metastases in newly diagnosed breast cancer: a populationbased study . JAMA Oncol . 2017 ; 3 ( 8 ): 1069 – 77 .

Pausch TM , Liu X , Cui J , Wei J , Miao Y , Heger U , et al . Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis . Cancers (Basel) . 2022 ; 14 ( 1 ): 57 .

Bhanvadia RR , 3rd Rodriguez J , Bagrodia A , Eggener SE . Lymph node count impacts survival following post-chemotherapy retroperitoneal lymphadenectomy for non-seminomatous testicular cancer: a population-based analysis . BJU Int . 2019 ; 124 ( 5 ): 792 – 800 .

Che W , Ma W , Lyu J , Wang X . Socioeconomic status and adult gliomas mortality risk: an observational study based on SEER data . World Neurosurg . 2021 ; 155 : e131 – 41 .

Saraswathula A , Megwalu UC . Insurance status and survival of patients with salivary gland cancer . Otolaryngol Head Neck Surg . 2018 ; 159 ( 6 ): 998 – 1005 .

Zhang SL , Wang WR , Liu ZJ , Wang ZM . Marital status and survival in patients with soft tissue sarcoma: a population-based, propensity-matched study . Cancer Med . 2019 ; 8 ( 2 ): 465 – 79 .

Zabor EC , Radivoyevitch T , Singh AD , Kilic E , de Klein JEMM , Kalirai H , et al . Conditional survival in uveal melanoma . Ophthalmol Retina . 2021 ; 5 ( 6 ): 536 – 42 .

Kitajima K , Igeta M , Kuyama J , Kawahara T , Suga T , Otani T , et al . Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 therapy in prostate cancer using bone scan index (J-RAP-BSI) trial . Eur J Nucl Med Mol Imaging . 2023 ; 50 ( 5 ): 1487 – 98 .

Wolbers M , Koller MT , Witteman JCM , Steyerberg EW . Prognostic models with competing risks: methods and application to coronary risk prediction . Epidemiology . 2009 ; 20 ( 4 ): 555 – 61 .

Latouche A , Allignol A , Beyersmann J , Labopin M , Fine JP . A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions . J Clin Epidemiol . 2013 ; 66 ( 6 ): 648 – 53 .

Fine JP , Gray RJ . A proportional hazards model for the subdistribution of a competing risk . J Am Stat Assoc . 1999 ; 94 ( 446 ): 496 – 509 .

Li Y , Sun L , Burstein DS , Getz KD . Considerations of competing risks analysis in cardio-oncology studies: JACC: cardiooncology state-of-theart review . JACC CardioOncol . 2022 ; 4 ( 3 ): 287 – 301 .

Li X , Liu Z , Ye Z , Gou S , Wang C . Impact of age on survival of patients with pancreatic cancer after surgery: analysis of SEER data . Pancreatology . 2018 ; 18 ( 1 ): 133 – 8 .

Gooley TA , Leisenring W , Crowley J , Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators . Stat Med . 1999 ; 18 ( 6 ): 695 – 706 .

Yang J , Pan Z , He Y , Zhao F , Feng X , Liu Q , et al . Competing-risks model for predicting the prognosis of penile cancer based on the SEER database . Cancer Med . 2019 ; 8 ( 18 ): 7881 – 9 .

Wold S . Spline functions in data analysis . Technometrics . 1974 ; 16 ( 1 ): 1 – 11 .

Stone CJ , Koo CY . Additive splines in statistics . In: Proceedings of the American Statistical Association . Washington DC ; 1985 . p. 45 – 8 .

2nd Herndon JE , Jr Harrell FE . The restricted cubic spline hazard model . Commun Stat-Theor M . 1990 ; 19 ( 2 ): 639 – 63 .

Frome EL , Kutner MH , Beauchamp JJ . Regression analysis of poissondistributed data . J Am Stat Assoc . 1973 ; 68 ( 344 ): 935 – 40 .

Frome EL , Checkoway H . Use of poisson regression models in estimating incidence rates and ratios . Am J Epidemiol . 1985 ; 121 ( 2 ): 309 – 23 .

Tsikitis VL , Wertheim BC , Guerrero MA . Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis . J Cancer . 2012 ; 3 : 292 .

Muskens IS , Feng Q , Francis SS , Walsh KM , Mckean-Cowdin R , Gauderman WJ , et al . Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis . Neurooncol Adv . 2020 ; 2 ( 1 ): vdaa089 .

Walker JP , Johnson JS , Eguchi MM , Saltzman AF , Cockburn M , Cost NG . Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review . J Pediatr Urol . 2020 ; 16 ( 1 ): 81 – 8 .

Iasonos A , Schrag D , Raj GV , Panageas KS . How to build and interpret a nomogram for cancer prognosis . J Clin Oncol . 2008 ; 26 ( 8 ): 1364 – 70 .

Bandini M , Marchioni M , Pompe RS , Tian Z , Gandaglia G , Fossati N , et al . First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy . BJU Int . 2018 ; 121 ( 4 ): 592 – 9 .

Pan X , Yang W , Chen Y , Tong L , Li C , Li H . Nomogram for predicting the overall survival of patients with inflammatory breast cancer: a SEER-based study . Breast . 2019 ; 47 : 56 – 61 .

Wu SL , Gai JD , Yu XM , Mao X , Jin F . A novel nomogram and risk classification system for predicting lymph node metastasis of breast mucinous carcinoma: a SEER-based study . Cancer Med . 2022 ; 11 ( 24 ): 4767 – 83 .

Kutikov A , Egleston BL , Wong YN , Uzzo RG . Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram . J Clin Oncol . 2010 ; 28 ( 2 ): 311 – 7 .

Yan B , Su BB , Bai DS , Qian JJ , Zhang C , Jin SJ , et al . A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma . Cancer Med . 2021 ; 10 ( 2 ): 496 – 506 .

Wang Y , Zheng Q , Jia B , An T , Zhao J , Wu M , et al . Effects of surgery on survival of early-stage patients with SCLC: propensity score analysis and nomogram construction in SEER database . Front Oncol . 2020 ; 10 : 626 .

Tibshirani R . Regression shrinkage and selection via the Lasso . J R Stat Soc B . 1996 ; 58 ( 1 ): 267 – 88 .

Zhao P , Yu B . On model selection consistency of Lasso . J Mach Learn Res . 2006 ; 7 : 2541 – 63 .

Yang Z , Shi G , Zhang P . Development and validation of nomograms to predict overall survival and cancer-specific survival in patients with pancreatic adenosquamous carcinoma . Front Oncol . 2022 ; 12 : 831649 .

Peng HT , Siddiqui MM , Rhind SG , Zhang J , da Luz LT , Beckett A . Artificial intelligence and machine learning for hemorrhagic trauma care . Mil Med Res . 2023 ; 10 ( 1 ): 6 .

Haug CJ , Drazen JM . Artificial intelligence and machine learning in clinical medicine, 2023 . N Engl J Med . 2023 ; 388 ( 13 ): 1201 – 8 .

Topol EJ . High-performance medicine: the convergence of human and artificial intelligence . Nat Med . 2019 ; 25 ( 1 ): 44 – 56 .

Yu H , Huang T , Feng B , Lyu J . Deep-learning model for predicting the survival of rectal adenocarcinoma patients based on a Surveillance, Epidemiology, and End Results analysis . BMC Cancer . 2022 ; 22 ( 1 ): 210 .

Senders JT , Staples P , Mehrtash A , Cote DJ , Taphoorn MJB , Reardon DA , et al . An online calculator for the prediction of survival in glioblastoma patients using classical statistics and machine learning . Neurosurgery . 2020 ; 86 ( 2 ): E184 – 92 .

Kim HJ , Fay MP , Feuer EJ , Midthune DN . Permutation tests for joinpoint regression with applications to cancer rates . Stat Med . 2000 ; 19 ( 3 ): 335 – 51 .

Lim H , Devesa SS , Sosa JA , Check D , Kitahara CM . Trends in thyroid cancer incidence and mortality in the United States, 1974–2013 . JAMA . 2017 ; 317 ( 13 ): 1338 – 48 .

Guo F , Kuo YF , Shih YCT , Giordano SH , Berenson AB . Trends in breast cancer mortality by stage at diagnosis among young women in the United States . Cancer . 2018 ; 124 ( 17 ): 3500 – 9 .

Lin D , Wang M , Chen Y , Gong J , Chen L , Shi X , et al . Trends in Intracranial Glioma Incidence and Mortality in the United States, 1975–2018 . Front Oncol . 2021 ; 11 : 748061 .

Rosenbaum PR , Rubin DB . The central role of the propensity score in observational studies for causal effects . Biometrika . 1983 ; 70 ( 1 ): 41 – 55 .

Staffa SJ , Zurakowski D . Five steps to successfully implement and evaluate propensity score matching in clinical research studies . Anesth Analg . 2018 ; 127 ( 4 ): 1066 – 73 .

Simoneau G , Pellegrini F , Debray TP , Rouette J , Muñoz J , Platt RW , et al . Recommendations for the use of propensity score methods in multiple sclerosis research . Mult Scler . 2022 ; 28 ( 9 ): 1467 – 80 .

Thomas L , Li F , Pencina M . Using propensity score methods to create target populations in observational clinical research . JAMA . 2020 ; 323 ( 5 ): 466 – 7 .

Qi L , Wan L , Ren X , Zhang W , Tu C , Li Z . The role of chemotherapy in extraskeletal osteosarcoma: a propensity score analysis of the surveillance epidemiology and end results (SEER) database . Med Sci Monit . 2020 ; 26 : e925107 .

Lim YJ , Song C , Kim JS . Improved survival with postoperative radiotherapy in thymic carcinoma: a propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database . Lung Cancer . 2017 ; 108 : 161 – 7 .

Liu Z , Zeng W , Huang L , Wang Z , Wang M , Zhou L , et al . Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis . Am J Cancer Res . 2018 ; 8 ( 8 ): 1440 – 8 .

Lin SW , Anisa KN . Effects of socioeconomic status on cancer patient survival: counterfactual event-based mediation analysis . Cancer Causes Control . 2021 ; 32 ( 1 ): 83 – 93 .

Leapman MS , Dinan M , Pasha S , Long J , Washington SL , Ma X , et al . Mediators of racial disparity in the use of prostate magnetic resonance imaging among patients with prostate cancer . JAMA Oncol . 2022 ; 8 ( 5 ): 687 – 96 .

Jiang X , Yan M . Surgical treatment for improved 1-year survival in patients with primary cardiac sarcoma . Anatol J Cardiol . 2021 ; 25 ( 11 ): 796 – 802 .

Liu X , Wang C , Feng Y , Shen C , He T , Wang Z , et al . The prognostic role of surgery and a nomogram to predict the survival of stage IV breast cancer patients . Gland Surg . 2022 ; 11 ( 7 ): 1224 – 39 .

Knoble NB , Alderfer MA , Hossain MJ . Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: analysis of SEER data . Cancer Epidemiol . 2016 ; 44 : 101 – 8 .

Kaplan NM , Sproul LE , Mulcahy WS . Large prospective study of ramipril in patients with hypertension . CARE Investig Clin Ther . 1993 ; 15 ( 5 ): 810 – 8 .

Sherman RE , Anderson SA , Dal Pan GJ , Gray GW , Gross T , Hunter NL , et al . Real-world evidence-what is it and what can it tell us . N Engl J Med . 2016 ; 375 ( 23 ): 2293 – 7 .

Corrigan-Curay J , Sacks L , Woodcock J . Real-world evidence and real-world data for evaluating drug safety and effectiveness . JAMA . 2018 ; 320 ( 9 ): 867 – 8 .

Fang Y , He W , Wang H , Wu M . Key considerations in the design of realworld studies . Contemp Clin Trials . 2020 ; 96 : 106091 .

Yuan QM , Lin TH , Jin K , Qiu S , Zhou XH , Jin D , et al . The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database . Asian J Androl . 2022 ; 24 ( 3 ): 305 – 10 .

Morgenstern H . Ecologic studies in epidemiology: concepts, principles, and methods . Annu Rev Public Health . 1995 ; 16 : 61 – 81 .

Mackenbach JP . Public health epidemiology . J Epidemiol Community Health . 1995 ; 49 ( 4 ): 333 – 4 .

Lai Y , Shi H , Wang Z , Feng Y , Bao Y , Li Y , et al . Incidence trends and disparities in Helicobacter pylori related malignancy among US adults, 2000–2019 . Front Public Health . 2022 ; 10 : 1056157 .

Che W , Liu J , Fu T , Wang X , Lyu J . Recent trends in synchronous brain metastasis incidence and mortality in the United States: ten-year multicenter experience . Curr Oncol . 2022 ; 29 ( 11 ): 8374 – 89 .

Horn SR , Stoltzfus KC , Mackley HB , Lehrer EJ , Zhou S , Dandekar SC , et al . Long-term causes of death among pediatric patients with cancer . Cancer . 2020 ; 126 ( 13 ): 3102 – 13 .

Monson RR . Analysis of relative survival and proportional mortality . Comput Biomed Res . 1974 ; 7 ( 4 ): 325 – 32 .

Lu Z , Teng Y , Ning X , Wang H , Feng W , Ou C . Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors . Cancer . 2022 ; 128 ( 18 ): 3330 – 9 .

Zaorsky NG , Churilla TM , Egleston BL , Fisher SG , Ridge JA , Horwitz EM , et al . Causes of death among cancer patients . Ann Oncol . 2017 ; 28 ( 2 ): 400 – 7 .

Comstock GW . Cohort analysis: W.H. Frost’s contributions to the epidemiology of tuberculosis and chronic disease . Soz Praventivmed . 2001 ; 46 ( 1 ): 7 – 12 .

Levin KA . Study design Ⅲ: cross-sectional studies . Evid Based Dent . 2006 ; 7 ( 1 ): 24 – 5 .

Wang X , Cheng Z . Cross-sectional studies: strengths, weaknesses, and recommendations . Chest . 2020 ; 158 ( 1S ): S65 – 71 .

Dey T , Mukherjee A , Chakraborty S . A practical overview of case-control studies in clinical practice . Chest . 2020 ; 158 ( 1S ): S57 – 64 .

Macki M , Air EL . Commentary: what is a case control study? . Neurosurgery . 2019 ; 85 ( 2 ): E390 – 1 .

Kooistra B , Dijkman B , Einhorn TA , Bhandari M . How to design a good case series . J Bone Joint Surg Am . 2009 ; 91 ( Suppl 3 ): 21 – 6 .

Dekkers OM , Egger M , Altman DG , Vandenbroucke JP . Distinguishing case series from cohort studies . Ann Intern Med . 2012 ; 156 ( 1 Pt 1 ): 37 – 40 .

Vuong HG , Nguyen TPX , Ngo HTT , Hassell L , Kakudo K . Malignant thyroid teratoma: an integrated analysis of case series/case reports . Endocr Relat Cancer . 2021 ; 28 ( 7 ): 495 – 503 .

Thiese MS . Observational and interventional study design types; an overview . Biochem Med (Zagreb) . 2014 ; 24 ( 2 ): 199 – 210 .

Duggan MA , Anderson WF , Altekruse S , Penberthy L , Sherman ME . The surveillance, epidemiology and end results (SEER) program and pathology: towards strengthening the critical relationship . Am J Surg Pathol . 2016 ; 40 ( 12 ): e94 – 102 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Data mining in clinical big data: the frequently used databases, steps, and methodological models

Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations

Sepsis in burns: lessons learned, challenges remain

Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers

The evolving burden of heart failure in China: a 34-year subnational analysis of trends and causes from the Global Burden of Disease Study 2023